Clinical Trial Update: A Study of Atezolizumab (Tecentriq) to Investigate Long-term Safety and Efficacy in Previously-treated Participants With Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) [Phase 4]

View source ↗

Summary

Phase 4 study evaluating long-term safety and efficacy of atezolizumab (Tecentriq) in previously treated locally advanced or metastatic non-small cell lung canc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Tecentriq (atezolizumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Carcinoma, Non-Small-Cell Lung | Phase 4 | Status: COMPLETED | Results posted: 2025-01-23